Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.377
Neutral
RSI(14)
42.819
Neutral
STOCH(KDJ)(9,3,3)
21.686
Neutral
ATR(14)
0.557
High Vlolatility
CCI(14)
-131.151
Sell
Williams %R
75.194
Sell
TRIX(12,20)
-0.002
Sell
StochRSI(14)
50.589
Buy
Sotera Health Co
SHC17.750USD
+0.350+2.01%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.04BMarket Cap
90.88P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Sotera Health Co
Currency: USD Updated: 2026-02-06Key Insights
Sotera Health Co's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.44.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sotera Health Co's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Sotera Health Co Highlights
StrengthsRisks
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Fairly Valued
The company’s latest PE is 90.88, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 227.77M shares, decreasing 9.21% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.30K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.39.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
20.438
Target Price
+17.46%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Sotera Health Co is 8.46, ranking 24 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 311.31M, representing a year-over-year increase of 9.05%, while its net profit experienced a year-over-year increase of 184.91%.
Score
Financials
6.26
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.68
Operational Efficiency
9.74
Growth Potential
10.00
Shareholder Returns
7.63
Sotera Health Co's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Sotera Health Co is 5.74, ranking 67 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 90.88, which is 119.17% below the recent high of 199.18 and 124.65% above the recent low of -22.40.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 24/75
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Sotera Health Co is 8.55, ranking 8 out of 75 in the Healthcare Providers & Services industry. The average price target is 19.50, with a high of 21.00 and a low of 16.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
20.438
Target Price
+17.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
67
Total
7
Median
9
Average
Company name
Ratings
Analysts
Sotera Health Co
SHC
11
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
28
HCA Healthcare Inc
HCA
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
23
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Sotera Health Co is 6.67, ranking 48 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 19.31 and the support level at 16.73, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
17.872
Sell
MA10
18.124
Sell
MA20
18.560
Sell
MA50
17.840
Sell
MA100
16.968
Buy
MA200
14.937
Buy
Institutional Confidence
Currency: USD Updated: 2026-02-06The current institutional shareholding score of Sotera Health Co is 7.00, ranking 38 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 80.17%, representing a quarter-over-quarter decrease of 12.09%. The largest institutional shareholder is The Vanguard, holding a total of 19.18M shares, representing 6.75% of shares outstanding, with 28.95% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Warburg Pincus LLC
Darsana Capital Partners LP
GTCR Golder Rauner, LLC
BlackRock Institutional Trust Company, N.A.
Sculptor Capital Management, Inc
Sessa Capital
T. Rowe Price Investment Management, Inc.
Sachem Head Capital Management LP
Janus Henderson Investors
1
2
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sotera Health Co is 8.38, ranking 11 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.83. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.83
VaR
+3.63%
240-Day Maximum Drawdown
+28.62%
240-Day Volatility
+45.13%
Return
Best Daily Return
60 days
+3.61%
120 days
+3.61%
5 years
+99.65%
Worst Daily Return
60 days
-2.55%
120 days
-3.77%
5 years
-33.27%
Sharpe Ratio
60 days
+2.22
120 days
+1.11
5 years
+0.15
Risk Assessment
Maximum Drawdown
240 days
+28.62%
3 years
+48.77%
5 years
+78.19%
Return-to-Drawdown Ratio
240 days
+1.11
3 years
+0.02
5 years
-0.08
Skewness
240 days
+3.10
3 years
+1.72
5 years
+11.59
Volatility
Realised Volatility
240 days
+45.13%
5 years
+56.00%
Standardised True Range
240 days
+2.72%
5 years
+3.48%
Downside Risk-Adjusted Return
120 days
+203.10%
240 days
+203.10%
Maximum Daily Upside Volatility
60 days
+21.37%
Maximum Daily Downside Volatility
60 days
+16.50%
Liquidity
Average Turnover Rate
60 days
+0.50%
120 days
+0.47%
5 years
--
Turnover Deviation
20 days
+38.70%
60 days
+13.65%
120 days
+6.46%
Peer Comparison
Healthcare Providers & Services
Sotera Health Co
SHC
7.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
ENSG
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
EHC
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Quest Diagnostics Inc
DGX
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Labcorp Holdings Inc
LH
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
